Early onset ofBC tends to occur with hormone receptor negativity in larger and more aggressive, high grade tumors with hormone receptor negativity, and HER2 overexpression (Assi et al., 2013), with greater risk of contralateral breast cancer in 15 years (Metcalfe et al., 2011). This evidence concerns the gene ERBB2 and breast carcinoma.